Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Newly Designed, Patent Pending Platelet Rich Plasma (PRP) Regenerative Medicine Therapy Created by Veterinarians, for Veterinarians has Launched from Enso Discoveries

Enso Discoveries has designed, patented, and university-validated an effective and low-cost Platelet Rich Plasma (PRP) kit for use in veterinary medicine


News provided by

Enso Discoveries

Apr 25, 2019, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Corey Orava, DVM, Chief Scientific Officer, Enso Discoveries
Corey Orava, DVM, Chief Scientific Officer, Enso Discoveries
Youtube
Youtube

MANHATTAN, Kan., April 25, 2019 /PRNewswire-PRWeb/ -- Enso Discoveries, LLC, Chief Scientific Officer Corey Orava, DVM, has successfully designed, patented and launched an affordable, effective, university-supported PRP kit for veterinarians. With the goal to constantly improve product and service offerings, create more in-clinic testing for veterinarians, and decrease overall cost and labor, Enso Discoveries has taken the lead in accessible, affordable, and personable veterinary regenerative medicine. These progressive developments are available to the market with little to no start-up fees, or long-term financial risk for new veterinarians and clinics.

"Enso Discoveries is proud to offer affordable solutions for acute, chronic and non-healing conditions. After ten years of working in the industry, Dr. Orava – who is widely regarded as one of the foremost industry leaders in regenerative medicine – has identified common obstacles that prevent veterinarians and pet/horse owners from fully utilizing these disease-modifying treatments. He began developing improvements to existing products and services that he believed should be more accessible, more effective, and less expensive," said Patrick Farley, CEO of Enso Discoveries.

As an equine practitioner, I can vouch for Enso Discoveries PRP kit being safe, efficacious and reliable, as I never have flare-ups or any problems, as is the case with some other kits.

Post this

Mr. Farley went on to say, "We know that having to buy expensive starter PRP packages, with centrifuges and multiple, costly, one-time-use kits upfront, is not what any veterinarian prefers to do. It's a lot of start-up equity and they are locked into one system – we hear this all the time. Our PRP kit answers this common issue by allowing anyone to try for under $100 – simply use your own centrifuge. If you happen to need a portable centrifuge, we offer those too at a very low cost."

Enso Discoveries is an emerging animal health company that has developed novel medical devices for the veterinary market, benefitting from designs made by veterinarians, for veterinarians. Consider a Platelet Rich Plasma (PRP) kit by Enso Discoveries for improved features including, but not limited to:

  • Collection tubes that fit into standard centrifuges (no capital equipment or initial investment required for new veterinarians/clinics to begin offering service)
  • Autologous product – no risk of rejection
  • Less invasive and time-consuming process – entire service can be completed in under 30 minutes (with the majority being performed by support staff/veterinary technicians)
  • A wide variety of applications ranging from orthopedics to theriogenology to dermatology and more (can be used as a stand-alone solution, or as an adjunct to surgery)
  • Application for slow or non-healing wounds
  • Use adjunct to dental surgery
  • Validated in 5 species

"As an equine practitioner, I can vouch for Enso Discoveries PRP kit being safe, efficacious and reliable, as I never have flare-ups or any problems, as is the case with some other kits. Enso has an excellent team of researchers and experts that I rely on to deliver the best products to help us do our job and keep our sport horses in the ring," said Josh Harvey, DVM, Outlaw Equine.

"Our clients [both small and large animal] are so pleased with this irreplaceable method of acute inflammation treatment. To use the animal's own body to heal itself is astonishing science. We really appreciate using the Enso Discoveries PRP kits as they are very easy to use, very affordable and we get excellent outcomes. Their technical support is really great too, if we have any questions. Dr. Orava is amazing with regenerative medicine," said Ann Buchanan, DVM, Deep Well Veterinary Service.

###

Our mission at Enso Discoveries is to greatly enhance the lives of animals through the development of cutting-edge, novel technology. We believe all things are possible. We offer a wide range of innovative services, university-backed science, and affordable medical products with an emphasis on regenerative medicine.

We continually perform and fund veterinary research with the help of our academic and industrial research partners. While maintaining the highest level of integrity, we continue to succeed because we support our products and services with scientific proof, superior sales and marketing ability, and a worldwide network of industry experienced contacts.

SOURCE Enso Discoveries

Related Links

http://www.ensodiscoveries.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.